STOCK TITAN

Wearable Devices (WLDS) CTO reports 72,917 shares plus options and RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Wearable Devices Ltd. filed an initial ownership report for Chief Technology Officer Langer Leeor Jacob. He directly holds 72,917 Ordinary Shares and stock options to acquire 125 additional Ordinary Shares at an exercise price of 316.8 per share, expiring on August 23, 2033.

The filing notes 6,250 Ordinary Shares issuable upon vesting of restricted share units in equal monthly installments of 1,042 shares through September 10, 2026, and 47,222 Ordinary Shares issuable upon vesting of restricted share units in equal monthly installments of 1,389 shares through January 1, 2029.

Positive

  • None.

Negative

  • None.
Insider Langer Leeor Jacob
Role Chief Technology Officer
Type Security Shares Price Value
holding Stock option (right to buy) -- -- --
holding Ordinary Shares -- -- --
Holdings After Transaction: Stock option (right to buy) — 125 shares (Direct); Ordinary Shares — 72,917 shares (Direct)
Footnotes (1)
  1. Includes (i) 6,250 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in equal monthly installments of 1,042 Ordinary Shares through September 10, 2026; and (ii) 47,222 Ordinary Shares issuable upon the vesting of RSUs in equal monthly installments of 1,389 Ordinary Shares through January 1, 2029. Each RSU represents the right to receive one Ordinary Share. The options were granted on August 23, 2023 and vest as follows: 42 options vest on the first year anniversary of the grant date and the remaining 83 options vest in equal monthly installments of 3 Ordinary Shares after the first anniversary.
Direct Ordinary Shares held 72,917 shares Total Ordinary Shares directly owned after reported holdings
Stock option exercise price 316.8 per share Exercise price for options on 125 Ordinary Shares
Option underlying shares 125 shares Underlying Ordinary Shares for reported stock options
RSUs vesting by 2026 6,250 shares Ordinary Shares issuable from RSUs vesting monthly through September 10, 2026
RSUs vesting by 2029 47,222 shares Ordinary Shares issuable from RSUs vesting monthly through January 1, 2029
RSU monthly vest tranche 1 1,042 shares Monthly RSU vesting installments through September 10, 2026
RSU monthly vest tranche 2 1,389 shares Monthly RSU vesting installments through January 1, 2029
Option expiration date August 23, 2033 Expiration for stock options on 125 Ordinary Shares
restricted share units ("RSUs") financial
"Includes (i) 6,250 ordinary shares ... issuable upon the vesting of restricted share units ("RSUs") in equal monthly installments..."
Stock option (right to buy) financial
"security_title": "Stock option (right to buy)""
Ordinary Shares financial
"Each RSU represents the right to receive one Ordinary Share."
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.
vesting financial
"issuable upon the vesting of RSUs in equal monthly installments..."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"exercisePrice": "316.8000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Langer Leeor Jacob

(Last)(First)(Middle)
5 HA-TNUFA STREET

(Street)
YOKNE'AM ILLIT2066736

(City)(State)(Zip)

ISRAEL

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
Wearable Devices Ltd. [ WLDS ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Technology Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares72,917(1)D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock option (right to buy)08/23/202408/23/2033Ordinary Shares125(2)$316.8D
Explanation of Responses:
1. Includes (i) 6,250 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in equal monthly installments of 1,042 Ordinary Shares through September 10, 2026; and (ii) 47,222 Ordinary Shares issuable upon the vesting of RSUs in equal monthly installments of 1,389 Ordinary Shares through January 1, 2029. Each RSU represents the right to receive one Ordinary Share.
2. The options were granted on August 23, 2023 and vest as follows: 42 options vest on the first year anniversary of the grant date and the remaining 83 options vest in equal monthly installments of 3 Ordinary Shares after the first anniversary.
/s/ Leeor Langer04/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Form 3 filing show for Wearable Devices (WLDS) CTO holdings?

The Form 3 shows CTO Langer Leeor Jacob directly holds 72,917 Ordinary Shares and stock options for 125 additional shares. It also discloses significant restricted share unit awards that may convert into Ordinary Shares as they vest over time.

How many restricted share units does the WLDS CTO have according to this filing?

The CTO has RSUs for 6,250 Ordinary Shares vesting in 1,042-share monthly installments through September 10, 2026, and 47,222 Ordinary Shares vesting in 1,389-share monthly installments through January 1, 2029. Each RSU represents the right to receive one Ordinary Share.

What stock options for Wearable Devices (WLDS) shares are reported for the CTO?

The filing reports stock options granted on August 23, 2023, to acquire 125 Ordinary Shares at an exercise price of 316.8 per share. These options expire on August 23, 2033 and vest over time according to a disclosed schedule.

How do the WLDS CTO’s options vest over time?

According to the filing, 42 options vest on the first anniversary of the August 23, 2023 grant date. The remaining 83 options vest in equal monthly installments of 3 Ordinary Shares after that first anniversary, creating a gradual vesting pattern through the term.

Are there buy or sell transactions in this Wearable Devices (WLDS) Form 3?

This Form 3 primarily reports existing holdings, not new market transactions. It lists direct ownership of 72,917 Ordinary Shares, stock options for 125 shares, and sizable RSU awards that will deliver additional shares if and when they vest over time.